A new study from the Department of Health and Human Services shows that policies in President Donald Trump's first administration helped lower some patients’ insulin costs below $35 for a 30-day supply.FOX Business obtained a copy of the new report set to be released as early as Monday. It shows the executive orders signed by Trump in his first term helped push the price of insulin lower.Trump signed four executive orders aimed at lowering costs of the life-saving treatment on July 24, 2020. The first ordered federally qualified health centers to pass along discounts received by drugmakers, in...
HALO NEWSLETTER
Join HALO today and unlock this story instantly — It's Free